Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors

NCT00876993 is registered in ClinicalTrials.gov with Johns Hopkins All Children's Hospital as lead sponsor.

NCT NCT00876993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Lead sponsor
Johns Hopkins All Children's Hospital
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2008
Completion date
September 30, 2015
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system tumors